CG Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $3.45M | Buy |
9,402
+1
| +0% | +$367 | 1.29% | 23 |
|
|
2016
Q3 | $3.78M | Sell |
9,401
-45
| -0.5% | -$18.1K | 1.41% | 20 |
|
|
2016
Q2 | $3.3M | Sell |
9,446
-250
| -3% | -$87.3K | 1.32% | 22 |
|
|
2016
Q1 | $3.5M | Sell |
9,696
-2,043
| -17% | -$736K | 1.4% | 24 |
|
|
2015
Q4 | $6.37M | Buy |
11,739
+266
| +2% | +$144K | 2.53% | 8 |
|
|
2015
Q3 | $5.34M | Buy |
11,473
+18
| +0.2% | +$8.37K | 2.26% | 11 |
|
|
2015
Q2 | $5.84M | Buy |
11,455
+165
| +1% | +$84.2K | 2.23% | 11 |
|
|
2015
Q1 | $5.1M | Buy |
11,290
+1,865
| +20% | +$842K | 1.98% | 15 |
|
|
2014
Q4 | $3.87M | Buy |
9,425
+30
| +0.3% | +$12.3K | 1.52% | 25 |
|
|
2014
Q3 | $3.39M | Buy |
9,395
+1,115
| +13% | +$402K | 1.39% | 23 |
|
|
2014
Q2 | $2.34M | Sell |
8,280
-2,370
| -22% | -$669K | 0.99% | 36 |
|
|
2014
Q1 | $3.2M | Buy |
10,650
+80
| +0.8% | +$24K | 1.44% | 22 |
|
|
2013
Q4 | $2.91M | Buy |
+10,570
| New | +$2.91M | 1.33% | 30 |
|